Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

about

Transcriptional regulation of chemokine expression in ovarian cancer VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.

P2860

Q26825361-2BB01B26-3A3B-4B0C-BF23-DA733B207A68 Q34328133-9362AEEE-EA67-4CDE-AAB7-EA96169CF269 Q35237915-773B4CCC-9175-44ED-8F8E-3AC7173B6C70

P2860

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

Item

http://www.wikidata.org/entity/Q36415124

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@ast

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@en

type

Item

label

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@ast

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@en

prefLabel

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@ast

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@en

P1476

Overexpressing the CCL2 chemok ...... ncy of in vivo tumourigenicity

@en

P2093

D Provencher

http://www.w3.org/2001/XMLSchema#string

K Gambaro

http://www.w3.org/2001/XMLSchema#string

M C J Quinn

http://www.w3.org/2001/XMLSchema#string

M de Ladurantaye

http://www.w3.org/2001/XMLSchema#string

P N Tonin

http://www.w3.org/2001/XMLSchema#string

P Wojnarowicz

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Integrated genomic analyses of ovarian carcinoma

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Primer3 on the WWW for general users and for biologist programmers

The UCSC Genome Browser Database

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

Ovarian surface epithelium: biology, endocrinology, and pathology

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

The three Es of cancer immunoediting

P2888

oncsis.2012.25

P304

e27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONCSIS.2012.25

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Marie Mes-Masson

P577

2012-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236103844

http://www.w3.org/2001/XMLSchema#string

P698

23552840

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

overexpression

P932

3503293

http://www.w3.org/2001/XMLSchema#string

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

about

P2860

P2860

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932